The illusion of safety: A report to the FDA on AI healthcare product approvals

The illusion of safety: A report to the FDA on AI healthcare product approvals

Saved in:

Bibliographic Details
Main Authors:	Rawan Abulibdeh, Leo Anthony Celi, Ervin Sejdić
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-06-01
Series:	PLOS Digital Health
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12140231/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Assessing the capture of sociodemographic information in electronic medical records to inform clinical decision making.
by: Rawan Abulibdeh, et al.
Published: (2025-01-01)

Preventing unrestricted and unmonitored AI experimentation in healthcare through transparency and accountability
by: Donnella S. Comeau, et al.
Published: (2025-01-01)

Overview of drugs approved by the FDA in 2022
by: D. V. Kurkin, et al.
Published: (2023-11-01)

FDA APPROVES NEW HEMOPHILIA DRUG
by: article Editorial
Published: (2025-02-01)

Statistical and Clustering Analysis of Safety Profiles of FDA-Approved Protein Kinase Inhibitors
by: Ioana Lavinia Radulian, et al.
Published: (2024-12-01)

FDA approved injection drug against schizophrenia
by: article Editorial
Published: (2023-07-01)

IL-15: from discovery to FDA approval
by: Zihai Li, et al.
Published: (2025-02-01)

Analysis of the measurements used as potency tests for the 31 US FDA-approved cell therapy products
by: Carl G. Simon, et al.
Published: (2025-03-01)

The FDA has approved the first treatment for Friedreich's ataxia
by: article Editorial
Published: (2023-05-01)

FDA approves belimumab for treatment of children with lupus nephritis
by: article Editorial
Published: (2022-10-01)

Bridging the Gap in FDA Approval for Pediatric Neuromodulation Devices
by: Ammar Shaikhouni, et al.
Published: (2025-01-01)

Patient reported outcomes in the FDA approved drugs for systemic rheumatic diseases (2013–2024)
by: Yan Xie, et al.
Published: (2025-05-01)

FDA APPROVED A NEW DRUG FOR THE TREATMENT OF ATOPIC DERMATITIS
by: article Editorial
Published: (2024-09-01)

THE FDA HAS APPROVED A NEW ANTIBIOTIC FOR THE TREATMENT OF UTIS
by: article Editorial
Published: (2025-05-01)

FDA HAS APPROVED THE LIQUID ADHD MEDICATION (NOT A STIMULANT)
by: article Editorial
Published: (2024-07-01)

The FDA has approved a new drug for the treatment of leukemia
by: article editorial
Published: (2024-12-01)

THE FDA HAS APPROVED A NEW COMBINED MENINGOCOCCAL VACCINE
by: article Editorial
Published: (2025-05-01)

FDA’s approval of resmetirom (Rezdiffra): a breakthrough in MASH management
by: Muhammad Mazhar Azam, et al.
Published: (2024-12-01)

Unveiling the Polypharmacological Potency of FDA-Approved Rebamipide for Alzheimer’s Disease
by: Israa J. Hakeem, et al.
Published: (2025-05-01)

FDA-approved kinase inhibitors in PROTAC design, development and synthesis
by: Kacper Kossakowski, et al.
Published: (2025-12-01)

The FDA has Approved Bozutinib for Children with Chronic Myelogenous Leukemia
by: article Editorial
Published: (2023-11-01)

The FDA has approved the first medical drug for Rett syndrome
by: article Editorial
Published: (2023-05-01)

FDA HAS APPROVED FIRST FCRN-BLOCKER FOR MYASTHENIA GRAVIS
Published: (2025-07-01)

THE FDA HAS APPROVED THE FIRST VACCINE AGAINST THE CHIKUNGUNYA VIRUS
by: article Editorial
Published: (2023-12-01)

THE FDA HAS APPROVED DUPILUMAB FOR THE PEDIATRIC TREATMENT OF ESOPHAGEAL DISEASES
by: article Editorial
Published: (2024-02-01)

THE FDA HAS APPROVED THE TRIPLE COMBINATION TOPICAL ACNE REMEDY
by: article Editorial
Published: (2023-12-01)

FDA Has Approved Evolocumab for Theatment of Familial Hypercholesterolemia in Children
by: article Editorial
Published: (2021-12-01)

FDA Has Approved First Drug for Treatment of Congenital Athymia
by: article Editorial
Published: (2021-12-01)

FDA HAS APPROVED NEW DRUG TREATMENT FOR HIV IN CHILDREN
by: article Editorial
Published: (2024-05-01)

FDA HAS APPROVED THE FIRST THERAPY FOR NEUROENDOCRINE TUMORS IN CHILDREN
by: article Editorial
Published: (2024-07-01)

FDA APPROVED THE FIRST NASAL SPRAY WITH ADRENALINE TO ELIMINATE ANAPHYLAXIS
by: article Editorial
Published: (2024-09-01)

THE FDA HAS APPROVED A NEW TREATMENT FOR HEMOPHILIA A OR B
by: Article Editorial
Published: (2024-11-01)

Evaluating the efficacy, safety, and immunogenicity of FDA-approved RSV vaccines: a systematic review of Arexvy, Abrysvo, and mResvia
by: Thamir A. Alandijany, et al.
Published: (2025-08-01)

FDA HAS APPROVED THE FIRST MEDICATION FOR RARE IMMUNITY-RELATED DISEASES
by: article Editorial
Published: (2024-07-01)

In silico repurposing of FDA-approved drugs as multi-target inhibitors of glioblastoma
by: Ridwan Abiodun Salaam, et al.
Published: (2025-03-01)

FDA HAS APPROVED NEW DRUG TREATMENT FOR DUCHENE MUSCULAR DYSTROPHY
by: article Editorial
Published: (2024-05-01)

Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
by: Zhonglei Wang, et al.
Published: (2025-05-01)

The illusion of empathy: evaluating AI-generated outputs in moments that matter
by: Alessia Dorigoni, et al.
Published: (2025-07-01)

FDA-approved phensuximide inhibits RIPK1-dependent immunogenic cell death
by: Byeong-Ju Kim, et al.
Published: (2025-06-01)

The FDA has approved the first gene therapy for the treatment of Duchennel's muscular dystrophy
by: article Editorial
Published: (2023-08-01)